BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8682076)

  • 1. Contributions of 31P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease.
    Neubauer S; Horn M; Pabst T; Gödde M; Lübke D; Jilling B; Hahn D; Ertl G
    Eur Heart J; 1995 Dec; 16 Suppl O():115-8. PubMed ID: 8682076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.
    Neubauer S; Krahe T; Schindler R; Horn M; Hillenbrand H; Entzeroth C; Mader H; Kromer EP; Riegger GA; Lackner K
    Circulation; 1992 Dec; 86(6):1810-8. PubMed ID: 1451253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac high-energy phosphate metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy.
    Neubauer S; Horn M; Pabst T; Harre K; Strömer H; Bertsch G; Sandstede J; Ertl G; Hahn D; Kochsiek K
    J Investig Med; 1997 Oct; 45(8):453-62. PubMed ID: 9394098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy.
    Hardy CJ; Weiss RG; Bottomley PA; Gerstenblith G
    Am Heart J; 1991 Sep; 122(3 Pt 1):795-801. PubMed ID: 1877457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy.
    Neubauer S; Horn M; Cramer M; Harre K; Newell JB; Peters W; Pabst T; Ertl G; Hahn D; Ingwall JS; Kochsiek K
    Circulation; 1997 Oct; 96(7):2190-6. PubMed ID: 9337189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.
    Beer M; Seyfarth T; Sandstede J; Landschütz W; Lipke C; Köstler H; von Kienlin M; Harre K; Hahn D; Neubauer S
    J Am Coll Cardiol; 2002 Oct; 40(7):1267-74. PubMed ID: 12383574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging.
    Hansch A; Rzanny R; Heyne JP; Leder U; Reichenbach JR; Kaiser WA
    Eur Radiol; 2005 Feb; 15(2):319-23. PubMed ID: 15630572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between plasma BNP level and the myocardial phosphocreatine/adenosine triphosphate ratio determined by phosphorus-31 magnetic resonance spectroscopy in patients with dilated cardiomyopathy.
    Chida K; Otani H; Kohzuki M; Saito H; Kagaya Y; Takai Y; Takahashi S; Yamada S; Zuguchi M
    Cardiology; 2006; 106(3):132-6. PubMed ID: 16636542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T; Naya M; Manabe O; Wakasa S; Kubota S; Chiba S; Iwano H; Yamada S; Yoshinaga K; Tamaki N; Tsutsui H; Matsui Y
    JACC Cardiovasc Imaging; 2011 Jul; 4(7):762-70. PubMed ID: 21757167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of 1H MR spectroscopy in the evaluation of myocardial metabolism in patients with dilated idiopathic cardiomyopathy: pilot study.
    Walecki J; Michalak MJ; Michalak E; Bilinska ZT; Ruzyllo W
    Acad Radiol; 2003 Oct; 10(10):1187-92. PubMed ID: 14587640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G; Perseghin G; De Cobelli F; Esposito A; Palloshi A; Lattuada G; Scifo P; Calori G; Del Maschio A; Margonato A
    Eur Heart J; 2006 Apr; 27(8):942-8. PubMed ID: 16510466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study.
    Beer M; Sandstede J; Weilbach F; Spindler M; Buchner S; Krug A; Köstler H; Pabst T; Kenn W; Landschütz W; von Kienlin M; Toyka KV; Ertl G; Gold R; Hahn D
    Rofo; 2001 May; 173(5):399-404. PubMed ID: 11414146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal and diffusely abnormal myocardium in humans: functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging.
    Auffermann W; Chew WM; Wolfe CL; Tavares NJ; Parmley WW; Semelka RC; Donnelly T; Chatterjee K; Higgins CB
    Radiology; 1991 Apr; 179(1):253-9. PubMed ID: 2006287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial high-energy phosphate metabolism in patients with stable chronic dilated cardiomyopathy under a dobutamine-induced prolonged mild workload.
    Nanbu T; Nakakoshi T; Yonezawa K; Kitabatake A
    Am Heart J; 1999 Oct; 138(4 Pt 1):641-5. PubMed ID: 10502208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy.
    Kalsi KK; Smolenski RT; Pritchard RD; Khaghani A; Seymour AM; Yacoub MH
    Eur J Clin Invest; 1999 Jun; 29(6):469-77. PubMed ID: 10354207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperpolarized (13)C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart.
    Schroeder MA; Lau AZ; Chen AP; Gu Y; Nagendran J; Barry J; Hu X; Dyck JR; Tyler DJ; Clarke K; Connelly KA; Wright GA; Cunningham CH
    Eur J Heart Fail; 2013 Feb; 15(2):130-40. PubMed ID: 23258802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of rapid-sequence 31P magnetic resonance spectroscopy in cardiac patients.
    Chida K; Otani H; Saito H; Nagasaka T; Kagaya Y; Kohzuki M; Zuguchi M; Shirato K
    Acta Radiol; 2005 Jul; 46(4):386-90. PubMed ID: 16134315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of exercise training on myocardial energy metabolism and ventricular function assessed by quantitative phosphorus-31 magnetic resonance spectroscopy and magnetic resonance imaging in dilated cardiomyopathy.
    Beer M; Wagner D; Myers J; Sandstede J; Köstler H; Hahn D; Neubauer S; Dubach P
    J Am Coll Cardiol; 2008 May; 51(19):1883-91. PubMed ID: 18466804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain death-induced alterations in myocardial workload and high-energy phosphates: a phosphorus 31 magnetic resonance spectroscopy study in the cat.
    Brandon Bravo Bruinsma GJ; Nederhoff MG; te Boekhorst BC; Bredée JJ; Ruigrok TJ; van Echteld CJ
    J Heart Lung Transplant; 1998 Oct; 17(10):984-90. PubMed ID: 9811406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [31P Magnetic Resonance Spectroscopy in Patients With Various Genesis of Left Ventricular Hypertrophy].
    Ternovoy SK; Mazaev VV; Stukalova OV; Serova NS
    Kardiologiia; 2015; 55(9):5-9. PubMed ID: 26898088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.